Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Levetiracetam
Keppra
Routinely available
SMC (661/10)
09/11/2023
Indication
Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in children and infants from 1 month of age to 4 years with epilepsy
Therapeutic Area
Central nervous system
Status Description
Routinely available
Formulation
100mg/ml oral solution
Comments
-
Link to Advice
Advice Published
17/01/2011
SMC Submission Type
Abbreviated
SMC Status
Restricted